DEFA14A: Premier to Go Private in $28.25/Share Patient Square Deal

Premier, Inc. announced its acquisition by Patient Square Capital for $28.25 per share, transitioning to a private company.

Summary

• Premier, Inc. will be acquired by an affiliate of Patient Square Capital in a take-private transaction.
• Stockholders will receive $28.25 in cash for each share upon the closing of the transaction.
• Premier's Board of Directors unanimously approved the acquisition, determining it to be in the best interests of the company and its stockholders, delivering immediate and certain value.
• The transaction is expected to be completed by the first quarter of calendar year 2026.
• Completion is contingent upon approval by Premier stockholders, satisfaction of regulatory approvals, and other customary closing conditions.
• Premier will continue to operate as a public company, with business as usual, until the transaction closes.

Sentiment

Score: 8

Explanation: The filing conveys a strong positive sentiment from management regarding the acquisition, emphasizing 'exciting update,' 'best interests,' 'immediate and certain value,' 'enhanced financial flexibility,' and 'accelerate advancement and tech-enablement.' While risks are acknowledged as legally required, the overall tone is highly optimistic about the strategic benefits and future potential under private ownership.

Positives

• Stockholders will receive immediate and certain value of $28.25 in cash per share.
• The Board of Directors unanimously determined the transaction is in the best interests of Premier and its stockholders.
• Patient Square Capital brings deep industry expertise, significant capital, and a strong track record to Premier.
• As a private company, Premier will benefit from enhanced financial flexibility and access to additional capital and resources.
• The acquisition is expected to accelerate the advancement and tech-enablement of Premier's product portfolio.
• Premier will be better positioned to capitalize on emerging opportunities and drive innovation.
• The deal is viewed as a testament to Premier's strength as an industry leader in supply chain expertise, world-class technology, and nationally recognized advisory capabilities.

Negatives

• Premier stock will no longer be listed or traded on NASDAQ or any other public exchange upon the closing of the transaction.
• Existing public shareholders will no longer participate in the future growth or appreciation of Premier as a publicly traded entity.

Risks

• Inability to consummate the proposed transaction within the anticipated time period, or at all, due to reasons such as failure to obtain required regulatory approvals, stockholder approval, or complete contemplated financing arrangements.
• Potential adverse effects on the market price of Premier Class A Common Stock due to announcements relating to the proposed transaction.
• Disruption from the proposed transaction making it more difficult to maintain business and operational relationships, including retaining and hiring key personnel and maintaining relationships with customers, vendors, and other business partners.
• The occurrence of any event, change, or other circumstances that could give rise to the termination of the merger agreement.
• Risks related to disruption of current plans and operations or the diversion of management's attention from ongoing business operations due to the proposed transaction.
• Significant transaction costs associated with the acquisition.
• Risk of litigation and/or regulatory actions related to the proposed transaction or unfavorable results from currently pending or future litigation and proceedings.

Future Outlook

Premier expects to complete the take-private transaction by the first quarter of calendar year 2026, subject to stockholder and regulatory approvals. As a private company under Patient Square Capital's ownership, Premier anticipates enhanced financial flexibility, access to additional capital, and resources to accelerate product portfolio advancement, tech-enablement, capitalize on emerging opportunities, and drive innovation.

Management Comments

• "I'm reaching out with an exciting update about the future of Premier."
• "This announcement is the result of our intentional strategy to best position Premier for the long term and benefit all stakeholders, particularly you – our valued partners."
• "Premier's Board of Directors carefully considered a wide range of strategic alternatives in recent years and unanimously determined that this transaction with Patient Square is in the best interests of Premier and its stockholders and, upon closing, will deliver immediate and certain value to our stockholders."
• "Patient Square has deep industry expertise, significant capital and a strong track record of successfully helping companies like Premier reach their full potential."
• "As a private company with Patient Square's financial support, Premier will benefit from access to additional capital and resources."
• "We expect to complete the transaction by the first quarter of calendar year 2026, subject to approval by Premier stockholders and satisfaction of regulatory approvals and other customary closing conditions."
• "Until then, we will continue to operate as a public company, and it is business as usual."
• "I hope you share in my enthusiasm for what's ahead. As always, thank you for your ongoing partnership and support."

Industry Context

This acquisition reflects a broader trend of private equity firms, particularly those specializing in healthcare, investing in established healthcare service and technology providers. Patient Square Capital's focus on improving health through products, services, and technologies aligns with Premier's role in supply chain, technology, and advisory services for healthcare providers. The move to take Premier private suggests a strategy to pursue long-term growth and innovation away from public market pressures, leveraging significant capital and industry expertise to enhance capabilities and market position in a dynamic healthcare landscape.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to assess the acquisition price or Premier's performance against global benchmarks.
• The strategic rationale of gaining 'enhanced financial flexibility' and 'access to additional capital and resources' through private ownership is a common justification for take-private transactions in various industries, including healthcare, where long-term investments in technology and infrastructure may be better supported outside the quarterly reporting cycle of public markets.

Corporate Governance

Legal Proceedings

• Risk of litigation and/or regulatory actions related to the proposed transaction.
• Risk of unfavorable results from currently pending litigation and proceedings or litigation and proceedings that could arise in the future.

Stakeholder Impact

• Shareholders: Will receive $28.25 in cash per share, providing immediate and certain value, but will no longer hold equity in the company post-acquisition.
• Partners (Customers/Contracted Suppliers): Assured that 'business as usual' will continue until closing, with expectations of future investment in capabilities to meet evolving needs and elevate patient care.
• Employees: Implied impact through the risk of difficulty in 'retaining and hiring key personnel' due to transaction disruption.
• Management: Attention may be diverted from ongoing business operations due to the transaction.

Next Steps

• Premier will file a Proxy Statement on Schedule 14A with the SEC.
• Premier stockholders will vote on the proposed transaction.
• Obtain necessary regulatory approvals.
• Satisfy other customary closing conditions.
• Complete the transaction by the first quarter of calendar year 2026.
• Premier will continue to operate as a public company until the transaction closes.

Key Dates

Recommendation

For existing shareholders, the recommendation is to hold shares until the transaction closes to receive the $28.25 cash per share, as the Board of Directors has unanimously approved the deal, stating it delivers 'immediate and certain value.' This implies a favorable outcome for shareholders, and holding ensures receipt of the agreed-upon cash consideration, assuming the transaction successfully closes.

Keywords

Premier Inc., Patient Square Capital, Acquisition, Take-private, Healthcare investment, Merger, Stockholder value, Supply chain, Healthcare technology, Advisory services, SEC filing, DEFA14A